These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21694760)

  • 1. Seroconverting blood donors as a resource for characterising and optimising recent infection testing algorithms for incidence estimation.
    Kassanjee R; Welte A; McWalter TA; Keating SM; Vermeulen M; Stramer SL; Busch MP
    PLoS One; 2011; 6(6):e20027. PubMed ID: 21694760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
    Kim AA; Rehle T
    AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower-sensitivity and avidity modifications of the vitros anti-HIV 1+2 assay for detection of recent HIV infections and incidence estimation.
    Keating SM; Hanson D; Lebedeva M; Laeyendecker O; Ali-Napo NL; Owen SM; Stramer SL; Moore RD; Norris PJ; Busch MP
    J Clin Microbiol; 2012 Dec; 50(12):3968-76. PubMed ID: 23035182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand.
    Young CL; Hu DJ; Byers R; Vanichseni S; Young NL; Nelson R; Mock PA; Choopanya K; Janssen R; Mastro TD; Mei JV
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):481-6. PubMed ID: 12882657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying major drivers of incident HIV infection using recent infection testing algorithms (RITAs) to precisely inform targeted prevention.
    Zhu Q; Wang Y; Liu J; Duan X; Chen M; Yang J; Yang T; Yang S; Guan P; Jiang Y; Duan S; Wang J; Jin C
    Int J Infect Dis; 2020 Dec; 101():131-137. PubMed ID: 32987184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a sensitive/less-sensitive testing algorithm using the 3A11-LS assay for detecting recent HIV seroconversion among individuals with HIV-1 subtype B or E infection in Thailand.
    Parekh BS; Hu DJ; Vanichseni S; Satten GA; Candal D; Young NL; Kitayaporn D; Srisuwanvilai LO; Rakhtam S; Janssen R; Choopanya K; Mastro TD
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):453-8. PubMed ID: 11282014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Biomarker-based HIV Incidence Estimation in the Treatment Era.
    Fellows IE; Hladik W; Eaton JW; Voetsch AC; Parekh BS; Shiraishi RW
    Epidemiology; 2023 May; 34(3):353-364. PubMed ID: 36863062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.
    Facente SN; Grebe E; Maher AD; Fox D; Scheer S; Mahy M; Dalal S; Lowrance D; Marsh K
    JMIR Public Health Surveill; 2022 Mar; 8(3):e34410. PubMed ID: 35275085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms.
    Grebe E; Welte A; Hall J; Keating SM; Facente SN; Marson K; Martin JN; Little SJ; Price MA; Kallas EG; Busch MP; Pilcher CD; Murphy G
    J Acquir Immune Defic Syndr; 2017 Dec; 76(5):547-555. PubMed ID: 28914669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral load criteria and threshold optimization to improve HIV incidence assay characteristics.
    Kassanjee R; Pilcher CD; Busch MP; Murphy G; Facente SN; Keating SM; Mckinney E; Marson K; Price MA; Martin JN; Little SJ; Hecht FM; Kallas EG; Welte A;
    AIDS; 2016 Sep; 30(15):2361-71. PubMed ID: 27454561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconciling HIV incidence results from two assays employed in the serological testing algorithm for recent HIV seroconversion (STARHS).
    Murphy G; Charlett A; Osner N; Gill ON; Parry JV
    J Virol Methods; 2003 Nov; 113(2):79-86. PubMed ID: 14553893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better control of early viral replication is associated with slower rate of elicited antiviral antibodies in the detuned enzyme immunoassay during primary HIV-1C infection.
    Novitsky V; Wang R; Kebaabetswe L; Greenwald J; Rossenkhan R; Moyo S; Musonda R; Woldegabriel E; Lagakos S; Essex M
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):265-72. PubMed ID: 19525854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.
    Janssen RS; Satten GA; Stramer SL; Rawal BD; O'Brien TR; Weiblen BJ; Hecht FM; Jack N; Cleghorn FR; Kahn JO; Chesney MA; Busch MP
    JAMA; 1998 Jul; 280(1):42-8. PubMed ID: 9660362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of mean recency period for estimation of HIV type 1 Incidence with the BED-capture EIA in persons infected with diverse subtypes.
    Parekh BS; Hanson DL; Hargrove J; Branson B; Green T; Dobbs T; Constantine N; Overbaugh J; McDougal JS
    AIDS Res Hum Retroviruses; 2011 Mar; 27(3):265-73. PubMed ID: 20954834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BED estimates of HIV incidence: resolving the differences, making things simpler.
    Hargrove J; van Schalkwyk C; Eastwood H
    PLoS One; 2012; 7(1):e29736. PubMed ID: 22235334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance.
    Sempa JB; Welte A; Busch MP; Hall J; Hampton D; Facente SN; Keating SM; Marson K; Parkin N; Pilcher CD; Murphy G; Grebe E;
    PLoS One; 2019; 14(7):e0220345. PubMed ID: 31348809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence.
    Kothe D; Byers RH; Caudill SP; Satten GA; Janssen RS; Hannon WH; Mei JV
    J Acquir Immune Defic Syndr; 2003 Aug; 33(5):625-34. PubMed ID: 12902808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short Communication: Defining optimality of a test for recent infection for HIV incidence surveillance.
    Kassanjee R; McWalter TA; Welte A
    AIDS Res Hum Retroviruses; 2014 Jan; 30(1):45-9. PubMed ID: 24090052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How should we best estimate the mean recency duration for the BED method?
    Hargrove J; Eastwood H; Mahiane G; van Schalkwyk C
    PLoS One; 2012; 7(11):e49661. PubMed ID: 23166743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.
    Schüpbach J; Gebhardt MD; Tomasik Z; Niederhauser C; Yerly S; Bürgisser P; Matter L; Gorgievski M; Dubs R; Schultze D; Steffen I; Andreutti C; Martinetti G; Güntert B; Staub R; Daneel S; Vernazza P
    PLoS Med; 2007 Dec; 4(12):e343. PubMed ID: 18052604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.